BACKGROUND:Women infected with human immunodeficiency virus (HIV) increasingly demonstrate abnormalities in fat distribution and metabolism; however, the effects of a home-based exercise regimen in this group have not been investigated. METHODS: We conducted a 16-week randomized intervention study of a supervised home-based progressive resistance training and aerobic exercise program in 40 HIV-infected women with increased waist-hip ratio and self-reported fat redistribution. Cross-sectional muscle area and muscle attenuation were measured by computed tomography. Cardiorespiratory fitness was determined by calculated maximum oxygen consumption (VO2max) and strength by 1-repetition maximum. RESULTS:Cardiorespiratory fitness (VO2max) was markedly lower at baseline (median [95% confidence interval], 15.4 [8.3-25.2] mL x kg(-1) x min(-1)) than reported values for healthy female subjects (26-35 mL x kg(-1) x min(-1)). Subjects randomized to exercise had significant improvement in mean +/- SEM VO2max (1.5 +/- 0.8 vs -2.5 +/- 1.6 mL x kg(-1) x min(-1); P<.001) and endurance (1.0 +/- 0.3 vs -0.6 +/- 0.3 minute; P<.001). Strength increased at the knee extensors, pectoralis, knee flexors, shoulder abductors, ankle plantar flexors, and elbow flexors (all P<.001). Total muscle area (6 +/- 1 vs 2 +/- 1 cm2; P = .02) and attenuation (2 +/- 1 vs -1 +/- 1 Hounsfield unit; P = .03) increased in the exercise group. No significant difference was seen in lipid levels, blood pressure, or abdominal visceral fat between the groups, but subjects randomized to exercise reported improved energy and appearance. CONCLUSIONS: A 16-week, supervised, home-based exercise regimen improved measures of physical fitness in HIV-infected women. The effects on strength were most significant, but improvements in cardiorespiratory fitness, endurance, and body composition were also seen.
RCT Entities:
BACKGROUND:Women infected with human immunodeficiency virus (HIV) increasingly demonstrate abnormalities in fat distribution and metabolism; however, the effects of a home-based exercise regimen in this group have not been investigated. METHODS: We conducted a 16-week randomized intervention study of a supervised home-based progressive resistance training and aerobic exercise program in 40 HIV-infectedwomen with increased waist-hip ratio and self-reported fat redistribution. Cross-sectional muscle area and muscle attenuation were measured by computed tomography. Cardiorespiratory fitness was determined by calculated maximum oxygen consumption (VO2max) and strength by 1-repetition maximum. RESULTS:Cardiorespiratory fitness (VO2max) was markedly lower at baseline (median [95% confidence interval], 15.4 [8.3-25.2] mL x kg(-1) x min(-1)) than reported values for healthy female subjects (26-35 mL x kg(-1) x min(-1)). Subjects randomized to exercise had significant improvement in mean +/- SEM VO2max (1.5 +/- 0.8 vs -2.5 +/- 1.6 mL x kg(-1) x min(-1); P<.001) and endurance (1.0 +/- 0.3 vs -0.6 +/- 0.3 minute; P<.001). Strength increased at the knee extensors, pectoralis, knee flexors, shoulder abductors, ankle plantar flexors, and elbow flexors (all P<.001). Total muscle area (6 +/- 1 vs 2 +/- 1 cm2; P = .02) and attenuation (2 +/- 1 vs -1 +/- 1 Hounsfield unit; P = .03) increased in the exercise group. No significant difference was seen in lipid levels, blood pressure, or abdominal visceral fat between the groups, but subjects randomized to exercise reported improved energy and appearance. CONCLUSIONS: A 16-week, supervised, home-based exercise regimen improved measures of physical fitness in HIV-infectedwomen. The effects on strength were most significant, but improvements in cardiorespiratory fitness, endurance, and body composition were also seen.
Authors: P C LaStayo; D J Pierotti; J Pifer; H Hoppeler; S L Lindstedt Journal: Am J Physiol Regul Integr Comp Physiol Date: 2000-05 Impact factor: 3.619
Authors: W P Fairfield; M Treat; D I Rosenthal; W Frontera; T Stanley; C Corcoran; M Costello; K Parlman; D Schoenfeld; A Klibanski; S Grinspoon Journal: J Appl Physiol (1985) Date: 2001-06
Authors: Martha Gulati; Henry R Black; Leslee J Shaw; Morton F Arnsdorf; C Noel Bairey Merz; Michael S Lauer; Thomas H Marwick; Dilip K Pandey; Roxanne H Wicklund; Ronald A Thisted Journal: N Engl J Med Date: 2005-08-04 Impact factor: 91.245
Authors: P T Katzmarzyk; A S Leon; T Rankinen; J Gagnon; J S Skinner; J H Wilmore; D C Rao; C Bouchard Journal: Metabolism Date: 2001-07 Impact factor: 8.694
Authors: C Hadigan; J B Meigs; C Corcoran; P Rietschel; S Piecuch; N Basgoz; B Davis; P Sax; T Stanley; P W Wilson; R B D'Agostino; S Grinspoon Journal: Clin Infect Dis Date: 2000-12-15 Impact factor: 9.079
Authors: Sara E Dolan; Colleen Hadigan; Kathleen M Killilea; Meghan P Sullivan; Linda Hemphill; Robert S Lees; David Schoenfeld; Steven Grinspoon Journal: J Acquir Immune Defic Syndr Date: 2005-05-01 Impact factor: 3.731
Authors: Nabila El-Bassel; John B Jemmott; J Richard Landis; Willo Pequegnat; Gina M Wingood; Gail Elizabeth Wyatt; Scarlett L Bellamy Journal: Arch Intern Med Date: 2011-04-25
Authors: S Adrian; A Scherzinger; A Sanyal; J E Lake; J Falutz; M P Dubé; T Stanley; S Grinspoon; J-C Mamputu; C Marsolais; T T Brown; K M Erlandson Journal: J Frailty Aging Date: 2019
Authors: Eugene Mutimura; Aimee Stewart; Nigel J Crowther; Kevin E Yarasheski; W Todd Cade Journal: Qual Life Res Date: 2008-03-05 Impact factor: 4.147